Related Experiment Video
Updated: May 3, 2026
08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
8.1K
[A gastric pacemaker in obese type 2 diabetic patients]
H J M Hein Handgraaf1, Rochelle M E H Nelissen, Rutgert Bianchi
1Atrium Medisch Centrum Parkstad, Heerlen.
Nederlands Tijdschrift Voor Geneeskunde
|February 12, 2014
Summary
A gastric pacemaker offers a promising alternative treatment for obesity and type 2 diabetes, aiding weight loss and improving glucose regulation without the negative side effects of insulin therapy.
Area of Science:
- Metabolic disorders
- Gastrointestinal surgery
Background:
- Obesity and type 2 diabetes mellitus present a significant global health challenge.
- Lifestyle changes are often unsuccessful, and insulin therapy can lead to adverse effects like weight gain and hypoglycemia.
- Gastric pacemakers offer a potential alternative treatment for this patient population.
Purpose of the Study:
- To evaluate the efficacy of gastric pacemakers in managing patients with both obesity and type 2 diabetes mellitus.
- To assess the impact of gastric pacemakers on weight reduction and glycemic control.
Main Methods:
- A laparoscopic implantation of a gastric pacemaker is utilized.
- The device employs non-excitatory stimulation to modulate gastric contractions.
- It stimulates vagal nerve afferent fibers to influence satiety centers and metabolic regulation.
Main Results:
- Patients experience significant weight loss.
- Improved glucose regulation is observed in treated individuals.
- The treatment avoids the adverse effects associated with insulin therapy.
Conclusions:
- Gastric pacemakers demonstrate potential as an effective therapeutic option for individuals with comorbid obesity and type 2 diabetes.
- Further research, including ongoing randomized trials, is crucial to confirm these findings and establish optimal treatment protocols.
![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:16Gastric Emptying
5.4K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
5.4K
01:21Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75